Pages that link to "Q26768471"

The following pages link to Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review (Q26768471):

Displaying 25 items.

• Epigenetic Biomarkers in Colorectal Cancer (Q30240778) (← links)
• Important molecular genetic markers of colorectal cancer. (Q37619856) (← links)
• Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients (Q37699262) (← links)
• Clinical and prognosis value of the CIMP status combined with MLH1 or p16 INK4a methylation in colorectal cancer (Q38668770) (← links)
• Epidemiology and biology of physical activity and cancer recurrence. (Q38670369) (← links)
• Current and future biomarkers in the treatment of colorectal cancer. (Q38787244) (← links)
• No association of CpG island methylator phenotype and colorectal cancer survival: population-based study. (Q40490322) (← links)
• CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers (Q41066289) (← links)
• Readers of DNA methylation, the MBD family as potential therapeutic targets. (Q45072707) (← links)
• Systems-epigenomics inference of transcription factor activity implicates aryl-hydrocarbon-receptor inactivation as a key event in lung cancer development. (Q47098327) (← links)
• Colorectal Cancers: An Update on Their Molecular Pathology (Q48182864) (← links)
• Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer. (Q50010486) (← links)
• Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers (Q50252299) (← links)
• Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters (Q50976223) (← links)
• A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway. (Q52682712) (← links)
• Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. (Q52802632) (← links)
• Characterizing Microsatellite Instability and Chromosome Instability in Interval Colorectal Cancers (Q58777847) (← links)
• Differences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer (Q61810809) (← links)
• Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis (Q64123101) (← links)
• Meta-analysis of the prognostic value of CpG island methylator phenotype in rectal cancer (Q89171911) (← links)
• Investigation of sirtuin 1 polymorphisms in relation to the risk of colorectal cancer by molecular subtype (Q89882336) (← links)
• A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival (Q92152049) (← links)
• The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer (Q92193162) (← links)
• Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3 (Q92246769) (← links)
• Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies (Q92914437) (← links)